Cardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share
Tweet
Share
E-mailGet Alerts CXM Hot Sheet
Price: $5.62 +0.54%
Revenue Growth %: -1.3%
Financial Fact:
Loss per common share - basic and diluted: -0.14
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: -1.3%
Financial Fact:
Loss per common share - basic and diluted: -0.14
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Cardium Therapeutics, Inc. (NYSE: CXM) reported Q1 EPS of ($0.02), versus ($0.02) reported last year.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Goldman Sachs Upgrades RENK Group AG (R3NK:GR) to Buy
- UBS Upgrades Kyocera (6971:JP) (KYOCY) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
